Rina M Mbofung

发表

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

J. McQuade, J. Wargo, A. Lazar, 2016, Cancer discovery.

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.

R. Davis, L. Garraway, Jing Wang, 2018, Cell metabolism.

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

K. Flaherty, Dennie T. Frederick, J. Wargo, 2012, Clinical Cancer Research.

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

J. McQuade, J. Wargo, A. Lazar, 2016, Cancer discovery.

The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy

R. Davis, C. Liu, A. Sood, 2017, Journal of the National Cancer Institute.

DEVELOPING NOVEL APPROACHES TO IMPROVE RESPONSE TO T CELL BASED CANCER IMMUNOTHERAPY

R. Mbofung, Rina M Mbofung, 2017 .

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

R. Davis, S. Hanash, Min Zhang, 2017, Nature Communications.

Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma

Jian Wang, H. Tawbi, P. Hwu, 2019, Clinical Cancer Research.

The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression

J. Wargo, R. Amaria, M. Davies, 2018, Clinical Cancer Research.

Off-the-Shelf, iPSC-Derived CAR-NK Cells Multiplexed-Engineered for the Avoidance of Allogeneic Host Immune Cell Rejection

K. Malmberg, Q. Hammer, Bahram Valamehr, 2021, Blood.

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

R. Amaria, P. Hwu, F. Muller, 2020, Cancer Immunology, Immunotherapy.